Brewing
the
future
of oils & fats.
A proprietary fermentation platform turning industrial side streams into high-performance lipid ingredients for personal care, food and specialty applications.
INVESTMENT SNAPSHOT
A platform entering its commercial scale-up phase.
Commercial product validation, global market access and a staged financing plan.
350bil
13.3M
40+
16+
WHY ÄIO
Commercial product validation, global market access.
Commercially launched cosmetics ingredients today. A six-family lipid platform for tomorrow. The investment thesis: scale manufacturing, improve unit economics and expand into new product categories.
The investment thesis: scale manufacturing, improve unit economics and expand into new product categories.
WHY NOW
A vast market needs new, resilient lipid supply.
Legacy petrochemical and agricultural supply chains face structural pressure.
01
SUPPLY RESILIENCE
Controlled fermentation reduces dependence on crops, climate and extractive supply chains.
02
SCALABLE BIOLOGY
Genomics, AI-enabled optimisation and renewable energy are accelerating biomanufacturing.
03
CUSTOMER PULL
Manufacturers are seeking palm, cocoa butter, butter, omega-3 and skin-active alternatives.
Beachhead market: $50B beauty & personal care market.
High-margin, innovation-led and fast product cycles.
TECHNOLOGY
One organism. Multiple lipid markets.
ÄIO combines proprietary microbes, fermentation and downstream processing into a versatile platform.
Platform breadth: C8 → C30+
1. SIDE-STREAMS
Low-value industrial, agricultural and dairy co-products.
2. FERMENTATION
Patent-pending process converts renewable carbon into lipids.
3. PRODUCTS
High-value oils, structured fats and specialty fatty acids.
FIRST COMMERCIAL PRODUCT
Fermira™ RedOil.
A premium bioactive oil combining distinctive colour, skin-benefit positioning, stability and a next-generation sustainability story.
Our first commercial product Fermira™ RedOil
- Skin renewal & longevity positioning
- Hydration and plumping effect
- Antioxidant activity
- High stability and shelf life
Market opportunity $2.4B
- $1.6B premium oils
- $0.8B anti-aging actives
Commercial signal €30–50/kg validated price
- First end-products launched tilk! serum, tilk! cream, JOIK re-boost
BUSINESS MODEL
From ingredient supplier to technology platform.
ÄIO combines proprietary microbes, fermentation and downstream processing into a versatile platform.
TODAY
ingredient sales
Cosmetics and food brands buy ÄIO ingredients. Regional distributors provide fast access to SMEs and global buyers.
SCALE UP
partnered production
CMO capacity evolves toward co-invested dedicated lines and an owned facility after Series B.
TOMORROW
technology licensing
License strains and processes to chemical and ingredient majors, enabling asset-light expansion.
2027-28
20-100 MT
CMO
2029
100-300 MT
Partner line
2031
1,000+ MT
Owned facility
2029+
10,000+ MT
Licensing
SERIES A
Series A fundraise now live.
A milestone-gated financing structure designed to preserve momentum while reducing execution risk.
- Expand commercial-scale production of fermentation-derived oils and fats, transforming proven technology into repeatable commercial supply with positive unit economics.
- Reduce production costs by up 50% through the development of next-generation fermentation technology, unlocking access to larger markets.
- Expand the product portfolio beyond first-generation cosmetic ingredients, including food ingredient launches.
- Develop and launch the technology licensing scaling model, creating an asset-light pathway to global scale through strategic manufacturing partners.
- Position ÄIO as the leading biomanufacturing platform for microbial fats and oils, addressing opportunities across the $350B global oils and fats market.
INVEST IN THE NEXT PRODUCTION PLATFORM FOR GLOBAL LIPIDS
Co-founder and CEO of ÄIO
nemailla@aio.bio • aio.bio
